Dirk Faict

2.2k total citations
54 papers, 1.7k citations indexed

About

Dirk Faict is a scholar working on Nephrology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dirk Faict has authored 54 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Nephrology, 10 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dirk Faict's work include Dialysis and Renal Disease Management (36 papers), Renal function and acid-base balance (9 papers) and Muscle and Compartmental Disorders (9 papers). Dirk Faict is often cited by papers focused on Dialysis and Renal Disease Management (36 papers), Renal function and acid-base balance (9 papers) and Muscle and Compartmental Disorders (9 papers). Dirk Faict collaborates with scholars based in Belgium, United Kingdom and United States. Dirk Faict's co-authors include Clifford J. Holmes, Norbert Lameire, Siska Mortier, An S. De Vriese, Nicholas Topley, Gerald A. Coles, Casper G. Schalkwijk, Anders Tranæus, Laurinda A. Cooker and Ruth Mackenzie and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Dirk Faict

53 papers receiving 1.6k citations

Peers

Dirk Faict
Dirk Faict
Citations per year, relative to Dirk Faict Dirk Faict (= 1×) peers Josef Zimmermann

Countries citing papers authored by Dirk Faict

Since Specialization
Citations

This map shows the geographic impact of Dirk Faict's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Faict with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Faict more than expected).

Fields of papers citing papers by Dirk Faict

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Faict. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Faict. The network helps show where Dirk Faict may publish in the future.

Co-authorship network of co-authors of Dirk Faict

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Faict. A scholar is included among the top collaborators of Dirk Faict based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Faict. Dirk Faict is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mortier, Siska, Dirk Faict, Norbert Lameire, & An S. De Vriese. (2005). Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model. Kidney International. 67(4). 1559–1565. 82 indexed citations
2.
Mortier, Siska, Dirk Faict, Marion Gericke, Norbert Lameire, & An S. De Vriese. (2005). Effects of New Peritoneal Dialysis Solutions on Leukocyte Recruitment in the Rat Peritoneal Membrane. Nephron Experimental Nephrology. 101(4). e139–e145. 18 indexed citations
3.
Mortier, Siska, Dirk Faict, Casper G. Schalkwijk, Norbert Lameire, & An S. De Vriese. (2004). Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane. Kidney International. 66(3). 1257–1265. 154 indexed citations
4.
Biesen, Wim Van, et al.. (2004). A Randomized Clinical Trial with a 0.6% Amino Acid/1.4% Glycerol Peritoneal Dialysis Solution. Peritoneal Dialysis International. 24(3). 222–230. 26 indexed citations
5.
Topley, Nicholas, et al.. (2003). The in vitro biocompatibility performance of a 25mmol/L bicarbonate/10mmol/L lactate-buffered peritoneal dialysis fluid. Kidney International. 64(88). S94–S99. 12 indexed citations
6.
Dratwa, Max, Martin Wilkie, Pieter M. ter Wee, et al.. (2003). Clinical experience with two physiologic bicarbonate/lactate peritoneal dialysis solutions in automated peritoneal dialysis. Kidney International. 64(88). S105–S113. 13 indexed citations
7.
Holmes, Clifford J. & Dirk Faict. (2003). Peritoneal dialysis solution biocompatibility: Definitions and evaluation strategies. Kidney International. 64(88). S50–S56. 22 indexed citations
8.
Zarei, Mohammad, Liesbeth H.P. Hekking, Inge L. Schadee–Eestermans, et al.. (2003). Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo. Nephrology Dialysis Transplantation. 18(12). 2629–2637. 58 indexed citations
9.
Vriese, An S. De, Siska Mortier, Maria Cornelissen, et al.. (2002). The Effects of Heparin Administration in an Animal Model of Chronic Peritoneal Dialysate Exposure. Peritoneal Dialysis International. 22(5). 566–572. 27 indexed citations
10.
Hekking, Liesbeth H.P., Mohammad Zarei, Dirk Faict, et al.. (2001). Better Preservation of Peritoneal Morphologic Features and Defense in Rats after Long-Term Exposure to a Bicarbonate/Lactate-Buffered Solution. Journal of the American Society of Nephrology. 12(12). 2775–2786. 88 indexed citations
11.
Jones, Suzanne, Clifford J. Holmes, Raymond T. Krediet, et al.. (2001). Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels. Kidney International. 59(4). 1529–1538. 132 indexed citations
12.
Mackenzie, Ruth, Suzanne Jones, Clifford J. Holmes, et al.. (2000). In vivo exposure to bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improves ex vivo peritoneal macrophage function. American Journal of Kidney Diseases. 35(1). 112–121. 40 indexed citations
13.
Mactier, Robert, Ram Gokal, Paul F. Williams, et al.. (1998). Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain. Kidney International. 53(4). 1061–1067. 6 indexed citations
14.
Mactier, Robert, Ram Gokal, Paul F. Williams, et al.. (1998). Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain. Kidney International. 53(4). 1061–1067. 106 indexed citations
15.
Coles, Gerald A., Dónal O’Donoghue, C S Ogg, et al.. (1998). A controlled trial of two bicarbonate-containing dialysis fluids for CAPD - Final report. Nephrology Dialysis Transplantation. 13(12). 3165–3171. 43 indexed citations
16.
Millar, David, C. J. Holmes, Dirk Faict, & Anne Dawnay. (1998). Comparison of in vitro AGE formation between standard PD fluid and a novel bicarbonate/lactate formulation.. PubMed. 14. 191–4. 23 indexed citations
17.
Sundaram, S., Laurinda A. Cooker, Bertrand L. Jaber, et al.. (1997). Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro. American Journal of Kidney Diseases. 30(5). 680–689. 47 indexed citations
18.
Biesen, Wim Van, Dirk Faict, Walther H. Boer, & Norbert Lameire. (1997). Further Animal and Human Experience with a 0.6% Amino Acid/1.4% Glycerol Peritoneal Dialysis Solution. Peritoneal Dialysis International. 17(2_suppl). 56–62. 7 indexed citations
19.
Lameire, Norbert & Dirk Faict. (1994). Peritoneal Dialysis Solutions Containing Glycerol and Amino Acids. Peritoneal Dialysis International. 14(3_suppl). 145–151. 6 indexed citations
20.
Topley, Nicholas, Meryl M. Petersen, David W. Williams, et al.. (1991). In Vitro Testing of a Potentially Biocompatible Continuous Ambulatory Peritoneal Dialysis Fluid. Nephrology Dialysis Transplantation. 6(8). 574–581. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026